Biology of Osteosarcoma (BOOST) Registry and Biobank

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03225872

Acronym

BOOST

Enrollment

362

Registered

2017-07-21

Start date

2017-01-03

Completion date

2020-01-27

Last updated

2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteosarcoma

Keywords

Osteosarcoma, Bone cancer, Family-based study

Brief summary

Osteosarcoma is very rare cancer of the bone. The investigator started the BOOST registry and biobank to make sure every patient has the opportunity to participate in research.

Detailed description

Summary to include: 1. Samples of saliva, blood and/or other stored material such as slides or leftover diagnostic material. If available the investigator may ask you for deciduous (baby) teeth. 2. Questionnaire information, including health history, growth and development, physical activity and family medical history information. 3. If you have been diagnosed with a osteosarcoma or another condition the investigator is interested inthe investigator will ask you release medical record information relating to diagnosis and treatment of osteosarcoma, other cancers, blood disorders, and similar conditions. If this step applies to you then you will be asked to sign a separate form. 4. You may be asked to contact your biological parents and full biological siblings to ask them about participating in the study. 5. If you agree you may be contacted in the future. You will be able to decline any future information or studies at any point.

Interventions

None listed

Study design

Observational model

FAMILY_BASED

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

0 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Proband Inclusion criteria: A diagnosis or suspected diagnosis of osteosarcoma (ICCC 9180-9200) Family member inclusion criteria: Biological parents and full biological siblings of a case diagnosed with osteosarcoma (ICCC 9180-9200)

Exclusion criteria

* Does not understand English.

Design outcomes

Primary

Measure	Time frame	Description
Determine if genes can determine osteosarcoma	Baseline	To do this the investigator will compare the genes of people with osteosarcoma to the genes of people who do not have these conditions.

Countries

United States

Outcome results